Психология стресса стр. 665
предрасположенность: Caspi, A., Sugden, K., Moffitt, T., Taylor, A., Craig, I., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwait, A., Poulton, R., “Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene,” Science 301 (2003): 386. Сходный результат получен на обезьянах: Bennett, A., Lesch, K., Heils, A., Long, J., Lorenz, J., Shoaf, S., Champoux, M., Suomi, S., Linnoila, M., Higley, J., “Early experience and serotonin transporter gene variation interact to influence primate CNS function,” Biological Psychiatry 7 (2002): 118.
С. 333. Низкие уровни глюкокортикоидов при атипичной депрессии: Gold, P., Chrousos, G., “Organization of the stress system and its dysregulation in melancholic and atypical depression: high versus low CRH/NE states,” Molecular Psychiatry 7 (2002) : 254-75.
С. 334. Обзор проблем обратной связи при депрессии: Pariante, C., Miller, A., “Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment,” Biological Psychiatry 49 (2001): 391.
С. 335. Стресс изменяет нейрохимические процессы, имеющие отношение к депрессии: Tafet, G., Bernardini, R., “Psychoneuroendocrinological links between chronic stress and depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (2003): 893; Sabban, E., Kvetnansky, R., “Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events,” Trends in Neurosciences 24 (2001): 91. Об интересной связи между глюкокортикоидами и нейрохимией серотонина см. в Glatz, K., Mossner, R., Heils, A., Lesch, K., “Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promoter-linked polymorphic region,” Journal of Neurochemistry 86 (2003): 1072. Также: van Riel, E., Meijer, O., Steenbergen, P., Joels, M., “Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons,” Neuroscience 120 (2003): 649. Демонстрацию того, что неконтролируемый стресс вызывает неконтролируемое изменение нейрохимии серотонина, см. в Bland, S., Twining, C., Watkins, L., Maier, S., “Stressor controllability modulates stress-induced serotonin but not dopamine efflux in the nucleus accumbens shell,” Synapse 49 (2003): 206.
С. 335. Последствия повышения уровней глюкокортикоидов при депрессии: иммунитет: Irwin, M., “Depression and immunity,” in Ader, R., Felten, D., Cohen, N., eds., Psychoneuroimmunology, 3d ed. (San Diego: Academic Press, 2001), vol. 2, 383. Осте- опороз: Cizza, G., Ravn, P., Chrousos, G., Gold, P., “Depression: a major, unrecognized risk factor for osteoporosis?” Trends in Endocrinology and Metabolism 12 (2001): 198. Болезни сердца: Penninx, B., Beekman, A., Honig, A., Deeg, D., Schoevers, R., van Eijk, J., van Tilburg, W., “Depression and cardiac mortality: results from a community- based longitudinal study,” Archives of General Psychiatry 58 (2001): 229; Ferketich, A., Schwartzbaum, J., Frid, J., Moeschberger, M., “Depression as an antecedent to heart disease among women and men in the NHANES I study,” National Health and Nutrition Examination Survey, Archives of Internal Medicine 9 (2000): 1261; Grippoa, A., Johnson, A., “Biological mechanisms in the relationship between depression and heart disease,” Neuroscience and Biobehavioral Reviews 26 (2002): 941.
С. 335. Атрофия гиппокампа при депрессии: Sheline, Y., Wang, P., Gado, M., Csernansky, J., Vannier, M., “Hippocampal atrophy in recurrent major depression,” Proceedings of the National Academy of Sciences, USA 93 (1996): 3908-4003; Sheline, Y., Sanghavi, M., Mintun, M., Gado, M.,
“Depression duration but